Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

Andrew R. Moore(University of Liverpool), D. Mark Pritchard(Istituti di Ricovero e Cura a Carattere Scientifico)

PLoS ONE

November 1, 2013

10.1371/annotation/4afd48b1-8dc0-47cc-9c8a-99aba7623116

Cited by 8

Related Papers

Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use

|PLoS Pathogens|2017|203

Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic Gastritis

|PLoS ONE|2013|62

Signaling mediated by the NF-κB sub-units NF-κB1, NF-κB2 and c-Rel differentially regulate Helicobacter felis-induced gastric carcinogenesis in C57BL/6 mice

|Oncogene|2013|36